Briefing: FDA launches unified system for adverse event reports
Strategic angle: BIO's Crowley warns U.S. risks losing lead, a familiar red flag with Aldeyra, and other biotech news from The Readout.
Editorial Staff Mar 12
Health
Latest Health stories from Life.
Briefing: Analysis of Medicare data shows who mental health providers treat over telehealth
Strategic angle: A new analysis reveals that mental health specialists utilizing telehealth did not significantly increase their rural patient base.
Editorial Staff Mar 12
Briefing: STAT+: Pharmalittle: We’re reading about telehealth prescribers, a Lilly push against compounding, and more
Strategic angle: Medical groups affiliated with telehealth companies the FDA warned about marketing of compounded weight loss drugs may be under the microscope, too
Editorial Staff Mar 12
Briefing: An NIH Whistleblower Warning
Strategic angle: The doctors behind the telehealth GLP-1 boom, a men's health office moment, and other health news
Editorial Staff Mar 12
Briefing: Officials Amplify Fluoride Concerns as Federal Review and State Restrictions Advance
Strategic angle: The EPA's safety review of fluoride coincides with growing state-level bans on community water fluoridation.
Editorial Staff Mar 12
Briefing: STAT+: Is Aldeyra Therapeutics waving red flags with consequences?
Strategic angle: How often do drugmakers complain about short sellers in SEC filings? And does it do any good?
Editorial Staff Mar 12
Briefing: FDA Targets Telehealth Marketing of GLP-1 Drugs
Strategic angle: The FDA is scrutinizing telehealth marketing practices for GLP-1 drugs, raising questions about prescribing trends.
Editorial Staff Mar 12
Briefing: Momentum builds for a federal office of men’s health focused on disease prevention
Strategic angle: For advocates who have been pushing to create a federal office of men's health, this could finally be the moment.
Editorial Staff Mar 12
Briefing: Key Facts About Medicare Drug Price Negotiation
Strategic angle: The federal government negotiates prices for high-cost drugs under Medicare Part B and Part D.
Editorial Staff Mar 11
Novo Nordisk is warned by the FDA for failing to report side effects
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.
Editorial Staff Mar 11
Briefing: This billionaire wants to make science better, especially for AI
Strategic angle: In this edition of AI Prognosis: Seemay Chou and Becky Pferdehirt's bold vision for how Radial will change science for AI
Editorial Staff Mar 11
Briefing: How Does Health Spending in the U.S. Compare to Other Countries?
Strategic angle: This analysis examines how U.S. health spending compares to health spending in other high-income nations.
Editorial Staff Mar 11
Briefing: Red states hit hardest by reduced NIH funding
Strategic angle: Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds
Editorial Staff Mar 11
Briefing: New nonprofit launches with at least $500 million to modernize scientific process for AI era
Strategic angle: Radial aims to transform the scientific landscape to better integrate artificial intelligence.
Editorial Staff Mar 11
Briefing: AI Agents in Health Care: Rapid Spread and Validation Concerns
Strategic angle: Experts at HIMSS 2026 raise alarms over the lack of validation for AI agents in health care.
Editorial Staff Mar 11
Briefing: Opinion: I’m a medical student. RFK Jr. is right about medical school and preventive care
Strategic angle: In medical school, a student writes, she has learned to react first, focus on prevention later.
Editorial Staff Mar 11
Briefing: STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
Strategic angle: Boris Nikolic’s career looked to be in tatters after his friendship with Jeffrey Epstein came to light in 2019. But he has quietly made a comeback, with some help from…
Editorial Staff Mar 11
Briefing: How Does Cost Affect Access to Health Care?
Strategic angle: This analysis explores trends in how the cost of healthcare affects access to care in the U.S.
Editorial Staff Mar 10
Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections
Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.
Editorial Staff Mar 10
Briefing: What’s next for RFK Jr.’s MAHA allies on vaccine policy?
Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.
Editorial Staff Mar 10